MaryRuth's, Liquid Morning Multivitamin + Hair Growth, Peach Mango, 15.22 fl oz (450 ml) vs Viviscal, Hair Growth Supplement, 60 Tablets: Multivitamin Comparison

Positioning: “daily multivitamin + hair/skin support” in one product. Best fit: - Users prioritizing convenience (liquid) + broad micronutrient coverage + cosmetic hair/skin support. Less fit: - Users seeking hormone/DHT modulation (not a core design on this label). - Users who want non-megadose biotin or who undergo frequent lab testing.

Target use-case (best-fit based on label + trial populations): • Adults with self-perceived hair thinning / increased shedding, especially “diffuse thinning” profiles. • Users who want a hair-focused supplement with published placebo-controlled evidence (3–6 months use). Less direct fit: • Users seeking DHT/hormone-targeting botanicals (none here). Hard exclusions (label): • Pregnant/nursing; under 18; seafood allergy (fish/mollusks).

Mechanism map (no promises; best-fit to label): • “Coverage”: broad multivitamin baseline (A, B-complex, C, D, E + choline + trace minerals). • Hair/skin lever: Lustriva® (biotin + silicon/arginine complex) aimed at thickness/appearance endpoints (ingredient-led evidence). • Minor add-ons: MSM, inositol, BCAA blend, betaine, hesperidin (likely supportive/marketing-level at listed doses). Boundaries: • Not a DHT-targeting botanical stack. • Faster “cosmetic timeline” claims are ingredient-led (e.g., Lustriva® study timelines), not proven for the finished liquid formula.

Mechanism map (no promises; based on label + clinical outcomes): • Core lever: marine protein/collagen complex (Aminomar) linked in RCTs to reduced shedding and improved hair metrics. • Shedding lever: reduced shedding over ~3 months in RCTs; may imply follicle-cycle shift (inferred from outcomes). • Fiber quality lever: small but significant increases in hair diameter reported in RCTs. • Nutrient support: iron + zinc + biotin + vitamin C (supportive, not a broad multivitamin). Boundaries / uncertainty: • Not positioned as DHT/hormone modulation. • Aminomar sub-component dosing is not disclosed → mechanism partly “black box” beyond observed endpoints.

Key branded complex: Lustriva® 160 mg per serving. Label discloses the complex name and its components: - Inositol-stabilized Arginine Silicate - Magnesium Biotinate Note: individual sub-component milligrams (e.g., silicon/arginine/biotinate breakdown) are NOT disclosed on the label.

Key proprietary ingredient: • Aminomar™ Marine Complex — 450 mg per tablet (900 mg/day). Label-listed components (within that line item): • Collagen Type II • Oyster extract powder Allergen context: • Contains fish (shark) and mollusks.

Transparency: PARTIAL. - Full mg/mcg disclosed for vitamins/minerals and several add-ons (inositol, MSM, betaine, hesperidin). - Partial for branded/blended items: Lustriva® and BCAA blend lack per-component mg breakdown. Bottom line: key hair-active (Lustriva®) has a disclosed total dose, but sub-components are opaque.

Dosage transparency = PARTIAL. Disclosed clearly: • Vitamins/minerals mg/mcg. • Horsetail and millet extract mg. Partly opaque: • Aminomar™ is disclosed as 450 mg total, but component doses inside the complex are not disclosed.

Hair-relevant nutrients (per 30 mL serving; label-disclosed): - Vitamin D3: 20 mcg (800 IU). - Folate (L-5-MTHF): 510 mcg DFE. - Biotin (magnesium biotinate): 10,000 mcg (megadose). - Zinc (citrate): 1 mg (low vs typical “hair formulas”). - Lustriva®: 160 mg (ingredient with hair thickness study data, but not this finished product).

Notable hair-relevant micronutrients (label): • Iron (ferrous fumarate): 10 mg per tablet (20 mg/day). • Zinc (zinc oxide): 11 mg per tablet (22 mg/day). • Biotin: 120 mcg per tablet (240 mcg/day). • Vitamin C (acerola + ascorbic acid): 59 mg per tablet (118 mg/day). • Niacin (niacinamide): 12 mg NE per tablet (24 mg/day). Note: zinc oxide is generally considered a lower-bioavailability zinc form vs chelates; label does not provide alternative forms.

Other notable label items (per 30 mL): - Vitamin A (beta-carotene) 1,010 mcg; Vitamin C 90 mg; Vitamin E 18 mg. - B-complex: B1 6 mg, B2 6.5 mg, niacinamide 32 mg, B6 8.5 mg, pantothenic acid 10 mg. - Choline 20 mg; Chromium picolinate 1,000 mcg. - Add-ons: inositol 50 mg; MSM 30 mg; BCAA complex 25 mg; betaine 10 mg; hesperidin 5 mg.

Other notable label items: • Calcium: 60 mg per tablet (120 mg/day) — low contribution vs typical daily needs. • Horsetail extract: 36.7 mg per tablet (73.4 mg/day). • Millet seed extract: 7.5 mg per tablet (15 mg/day). • Total carbohydrate: <1 g per tablet (negligible). No additional amino acid “builders” (e.g., cysteine/methionine/lysine) are disclosed on this label.

Biotin per serving: 10,000 mcg (33,333% DV). Declared form: Biotin (as Magnesium Biotinate). Interpretation: megadose tier (hair/skin marketing dose range).

Biotin (label): • 120 mcg per 1 tablet. • 240 mcg/day at the recommended 2 tablets/day. Biotin form: • Not disclosed (listed simply as “Biotin”).

Direct “structural builders” for hair shaft: - Silicon source is implied via arginine silicate (inside Lustriva®), but silicon mg is NOT disclosed. - BCAA blend exists (25 mg total) — nutritionally trivial vs dietary protein; likely not a meaningful keratin substrate. - MSM is present (30 mg) — far below typical gram-range dosing used in MSM studies. Not on label: collagen/keratin/cysteine/lysine-focused dosing.

Structural “builders” for hair shaft (what’s actually present): • Aminomar™ marine complex includes collagen/protein fractions (collagen type II; oyster extract powder listed). • Vitamin C supports collagen synthesis pathways (supportive, not hair-specific). • Horsetail is often used as a “silica” herb, but silica content is NOT disclosed/standardized here. Not present / not disclosed: • No explicit keratin, L-cysteine, L-methionine, L-lysine, MSM (not found on label).

Brand claim: “thicker, fuller hair… as early as 3 weeks” (ingredient-led claim tied to Lustriva® messaging). Reality check: - Hair cycle biology commonly needs ~8–12+ weeks for meaningful density/thickness changes; early “3-week” changes may reflect measurement sensitivity or cosmetic perception. Evidence type: marketing/ingredient claim, not finished-product proof.

Time-to-results claim (label): • Take for 3–6 months. • “May start seeing results in as little as 3 months”; 6 months recommended for thicker, fuller hair. Claim vs biology: • Hair-cycle timelines make a multi-month window plausible; short “weeks-level” promises are not the core claim here.

Clinical evidence status: - Finished product (this liquid multivitamin): NO peer-reviewed, placebo-controlled RCT located. - Ingredient-level: Lustriva® (biotin + silicon/arginine complex) has at least one double-blind, placebo-controlled trial in women reporting improved hair thickness and skin endpoints. Strength note: - Evidence is primarily “ingredient RCT → extrapolated to product,” which is weaker than a finished-product RCT.

Finished-product evidence exists (placebo-controlled human RCTs) for Viviscal/AminoMar-based formulas. Key examples (women): • 3-month double-blind RCT: Viviscal Extra Strength (twice daily) increased terminal hair count and reduced shedding vs placebo (Ablon 2015). • 6-month multisite double-blind RCT: marine/AminoMar-based supplement reduced shedding and increased fine-hair diameter vs placebo (Rizer et al. 2015; PMC available). • 6-month double-blind RCT: “Viviscal Professional Strength” improved terminal hair growth and hair diameter vs placebo (Ablon et al. 2015; PMC available). Men: • 6-month double-blind RCT: Viviscal Man improved hair counts/density and reduced hair-pull shedding vs placebo (Ablon 2016). Limitations: • Manufacturer involvement/sponsorship is common across this evidence base; independent replication would strengthen confidence.

Study independence: NOT verifiable from label. Likely scenario: - Ingredient studies around Lustriva® are commonly tied to ingredient commercialization (possible manufacturer involvement). Confidence note: - Without full funding/COI statements for each paper, treat independence as uncertain.

Study independence (bias risk): • Multiple placebo-controlled trials exist, but manufacturer involvement is common (e.g., trials explicitly identify Viviscal/Lifes2good; some include company-linked authors or funding). Practical interpretation: • Evidence is stronger than “ingredient-only marketing”, but not the same as fully independent replication across multiple unrelated teams.

Flag: YES — high-dose biotin. Label warning: “Biotin may interfere with some blood test results.” Why it matters (independent safety guidance): - Can cause falsely high/low results in certain immunoassays (notably some thyroid panels and cardiac troponin assays). Actionable user note: disclose high-dose biotin use to clinician/lab before bloodwork.

Lab-test interference risk (biotin): • FDA warns biotin can interfere with certain lab tests (including troponin; also many immunoassays). Dose realism for THIS product: • At 240 mcg/day (recommended use), this is far below “high-dose biotin” regimens (often ≥5,000 mcg/day) most associated with clinically significant interference. Practical rule: • Risk is likely LOW at label dose, but disclose use before sensitive labs, especially if stacking other biotin products.

No iodine/kelp indicated on the Supplement Facts label. Not disclosed: any iodine content from “evaporated sea water” (listed in Other Ingredients) is not quantified as iodine on the label.

Iodine/kelp/seaweed flag: • No iodine or kelp/seaweed ingredients indicated on the Supplement Facts label. Not found on label.

Major GI irritants (piperine/capsaicin/black pepper): NOT found on label. Possible tolerance notes (not guaranteed): - Liquid glycerin/xanthan + acidic components can bother sensitive users, especially on an empty stomach. Not verifiable from label: actual GI tolerability rate.

GI irritation flags: • No classic GI irritants/absorption boosters listed (no piperine/capsaicin). • Iron (ferrous fumarate) can cause GI effects in some users (nausea, constipation), especially if taken without adequate food. Net: mild GI risk mainly driven by iron sensitivity.

High “upper-limit pressure” signals: - Biotin: 10,000 mcg (megadose; primary practical risk = lab test interference). - Chromium: 1,000 mcg (very high vs typical supplemental intakes; caution with glucose-control meds). Moderate/high but not extreme (per label): - Niacinamide 32 mg; B6 8.5 mg; multiple B-vitamins at 500% DV. Not disclosed: no iron on the label (reduces one common UL concern).

Upper-limit (UL) pressure check at recommended 2 tablets/day: • Iron: 20 mg/day (adult UL = 45 mg/day) → below UL, but meaningful dose; stacking iron can push higher. • Zinc: 22 mg/day (adult UL = 40 mg/day) → below UL; stacking zinc can push toward UL. • Niacin: 24 mg NE/day; UL for niacin is 35 mg/day (note: UL is mainly based on flushing with nicotinic acid; niacinamide differs, but label uses niacinamide). Net: UL pressure = low-to-moderate, mainly relevant if the user stacks multiple multis/minerals.

Key safety precautions (label + independent safety guidance): - High-dose biotin (10,000 mcg): can interfere with certain lab tests (thyroid panels, some troponin assays). Disclose before bloodwork. - Pregnancy/lactation: label advises clinician consultation. - Chromium picolinate (1,000 mcg): high dose; caution if using glucose-lowering medications or managing diabetes (potential interaction risk). - Stacking: avoid combining with other high-dose biotin/B-complex products unless intentionally supervised. Allergen note: label/description indicates vegan formula; no fish/shellfish actives disclosed.

Key safety / contraindications (label + high-quality safety guidance): Label warnings: • NOT intended for pregnant or nursing women; NOT for persons under 18. • Iron overdose warning for children: keep out of reach; seek urgent help in overdose. • If taking medications, consult a clinician before use. Allergen warnings: • Contains fish (shark) and mollusks (oyster) → avoid if seafood allergy. Iron-specific cautions (practical): • 20 mg/day iron at recommended use: consider avoidance/clinician guidance for men, postmenopausal women, hemochromatosis, or those already supplementing iron. Biotin / lab tests: • FDA warns biotin can interfere with some lab tests; this product’s biotin dose is low, but disclose supplement use before critical labs (especially if stacking biotin).